Compounds > 6,6'-methylenebis(2,2-dimethyl-4-methanesulfonic acid-1,2-dihydroquinoline)
Page last updated: 2024-09-03

6,6'-methylenebis(2,2-dimethyl-4-methanesulfonic acid-1,2-dihydroquinoline) and Coronary Disease

6,6'-methylenebis(2,2-dimethyl-4-methanesulfonic acid-1,2-dihydroquinoline) has been researched along with Coronary Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morvay, G; Pollák, Z; Röth, E; Temes, G; Török, B1
Bär, V; Mezey, B; Röth, E; Temes, G; Törók, B; Tóth, K1

Other Studies

2 other study(ies) available for 6,6'-methylenebis(2,2-dimethyl-4-methanesulfonic acid-1,2-dihydroquinoline) and Coronary Disease

ArticleYear
Myocardial protection by antioxidant during permanent and temporary coronary occlusion in dogs.
    Basic research in cardiology, 1987, Volume: 82 Suppl 2

    Topics: Animals; Antioxidants; Coronary Disease; Coronary Vessels; Dogs; Microscopy, Electron; Myocardium; Quinolines

1987
[Inhibition of ventricular fibrillation in experimental acute coronary occlusion by means of free radical-binding compounds].
    Orvosi hetilap, 1986, Sep-28, Volume: 127, Issue:39

    Topics: Animals; Coronary Disease; Dogs; Drug Evaluation, Preclinical; Injections, Intravenous; Quinolines

1986